Tag archives: disclosure

Activist Pershing Square Teams Up With Valeant Pharmaceuticals To Target Allergan Inc.

This blog post was written by Andrea Campbell and originally appeared in Norton Rose Fulbright’s Special Situations blog. Shareholder activism has been dubbed “the new M&A” in recognition of activists’ propensity to drive companies to pursue value-creating transactions.  Last month, Bill Ackman’s Pershing Square Capital Management took this trend to a new level when it teamed up … Continue reading
LexBlog